Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells. Yahyapour A, Askari N, Yaghoobi MM. BMC Cancer 2025;25:1427.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yahyapour A, Askari N, Yaghoobi MM. Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells. BMC Cancer 2025;25:1427.
PMID: 40993589